Omega-3 and omega-6 fatty acid levels in depressive and anxiety disorders
- 1 January 2018
- journal article
- research article
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 87, 53-62
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profileBMC Medicine, 2013
- Association of depressive disorders, depression characteristics and antidepressant medication with inflammationTranslational Psychiatry, 2012
- Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysisMolecular Psychiatry, 2011
- Essential fatty acids and mood: A systematic review of observational studiesAmerican Journal of Food and Nutrition, 2011
- n–3 Fatty Acids and Cardiovascular Events after Myocardial InfarctionNew England Journal of Medicine, 2010
- Serum levels of brain-derived neurotrophic factor in major depressive disorder: state–trait issues, clinical features and pharmacological treatmentMolecular Psychiatry, 2010
- Identifying Depressive Subtypes in a Large Cohort StudyThe Journal of Clinical Psychiatry, 2010
- Updated systematic review and meta-analysis of the effects of n−3 long-chain polyunsaturated fatty acids on depressed moodThe American Journal of Clinical Nutrition, 2010
- Major depression: the importance of clinical characteristics and treatment response to prognosisDepression and Anxiety, 2009
- Late-onset major depression: clinical and treatment-response variabilityInternational Journal of Geriatric Psychiatry, 2005